STERIALS

The company is a biopharmaceutical company primarily engaged in the research, development, production and global commercialization of pharmaceuticals. Its research and development focuses on the therapeutic areas of cancer, rare genetics and hematology, neuroscience and gastrointestinal diseases, and it also invests in targeted R&D projects such as plasma-derived therapies and vaccines. It sells drugs for the treatment of ulcerative colitis and Crohn's disease, and for the prevention of hereditary angioedema.